{"count":22,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/b5326e89-bbc1-41d2-8020-6a9817c92b9d/","filing_uuid":"b5326e89-bbc1-41d2-8020-6a9817c92b9d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5326e89-bbc1-41d2-8020-6a9817c92b9d/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Corredor","dt_posted":"2026-04-15T08:09:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11400 Rockville Pike","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401104864,"url":"https://lda.gov/api/v1/registrants/401104864/","house_registrant_id":null,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","description":"Medical Professional Society","address_1":"11400 Rockville Pike","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROLYN C. LANHAM","contact_telephone":"+1 301-547-4104","dt_updated":"2026-07-17T06:37:18.428913-04:00"},"client":{"id":202836,"url":"https://lda.gov/api/v1/clients/202836/","client_id":12,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","general_description":"Medical Professional Society","client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-05-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5326e89-bbc1-41d2-8020-6a9817c92b9d/","filing_uuid":"b5326e89-bbc1-41d2-8020-6a9817c92b9d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5326e89-bbc1-41d2-8020-6a9817c92b9d/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Corredor","dt_posted":"2026-04-15T08:09:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11400 Rockville Pike","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401104864,"url":"https://lda.gov/api/v1/registrants/401104864/","house_registrant_id":null,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","description":"Medical Professional Society","address_1":"11400 Rockville Pike","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROLYN C. LANHAM","contact_telephone":"+1 301-547-4104","dt_updated":"2026-07-17T06:37:18.428913-04:00"},"client":{"id":202836,"url":"https://lda.gov/api/v1/clients/202836/","client_id":12,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","general_description":"Medical Professional Society","client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-05-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5326e89-bbc1-41d2-8020-6a9817c92b9d/","filing_uuid":"b5326e89-bbc1-41d2-8020-6a9817c92b9d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5326e89-bbc1-41d2-8020-6a9817c92b9d/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Corredor","dt_posted":"2026-04-15T08:09:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11400 Rockville Pike","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401104864,"url":"https://lda.gov/api/v1/registrants/401104864/","house_registrant_id":null,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","description":"Medical Professional Society","address_1":"11400 Rockville Pike","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROLYN C. LANHAM","contact_telephone":"+1 301-547-4104","dt_updated":"2026-07-17T06:37:18.428913-04:00"},"client":{"id":202836,"url":"https://lda.gov/api/v1/clients/202836/","client_id":12,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","general_description":"Medical Professional Society","client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-05-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5326e89-bbc1-41d2-8020-6a9817c92b9d/","filing_uuid":"b5326e89-bbc1-41d2-8020-6a9817c92b9d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5326e89-bbc1-41d2-8020-6a9817c92b9d/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Corredor","dt_posted":"2026-04-15T08:09:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11400 Rockville Pike","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401104864,"url":"https://lda.gov/api/v1/registrants/401104864/","house_registrant_id":null,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","description":"Medical Professional Society","address_1":"11400 Rockville Pike","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROLYN C. LANHAM","contact_telephone":"+1 301-547-4104","dt_updated":"2026-07-17T06:37:18.428913-04:00"},"client":{"id":202836,"url":"https://lda.gov/api/v1/clients/202836/","client_id":12,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","general_description":"Medical Professional Society","client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-05-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5326e89-bbc1-41d2-8020-6a9817c92b9d/","filing_uuid":"b5326e89-bbc1-41d2-8020-6a9817c92b9d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5326e89-bbc1-41d2-8020-6a9817c92b9d/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Corredor","dt_posted":"2026-04-15T08:09:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11400 Rockville Pike","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401104864,"url":"https://lda.gov/api/v1/registrants/401104864/","house_registrant_id":null,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","description":"Medical Professional Society","address_1":"11400 Rockville Pike","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROLYN C. LANHAM","contact_telephone":"+1 301-547-4104","dt_updated":"2026-07-17T06:37:18.428913-04:00"},"client":{"id":202836,"url":"https://lda.gov/api/v1/clients/202836/","client_id":12,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","general_description":"Medical Professional Society","client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-05-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5326e89-bbc1-41d2-8020-6a9817c92b9d/","filing_uuid":"b5326e89-bbc1-41d2-8020-6a9817c92b9d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5326e89-bbc1-41d2-8020-6a9817c92b9d/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kelly Corredor","dt_posted":"2026-04-15T08:09:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11400 Rockville Pike","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":401104864,"url":"https://lda.gov/api/v1/registrants/401104864/","house_registrant_id":null,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","description":"Medical Professional Society","address_1":"11400 Rockville Pike","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CAROLYN C. LANHAM","contact_telephone":"+1 301-547-4104","dt_updated":"2026-07-17T06:37:18.428913-04:00"},"client":{"id":202836,"url":"https://lda.gov/api/v1/clients/202836/","client_id":12,"name":"AMERICAN SOCIETY OF ADDICTION MEDICINE","general_description":"Medical Professional Society","client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-05-01"},"lobbying_activities":[{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Advocated for increased FY27 funding for HRSA's Addiction Medicine Fellowship Program ($30M) and discussed with HRSA officials ways to increase the addiction specialist physician workforce pipeline Advocated for increased FY27 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter urging House and Senate appropriations leaders to pass a full-year Labor, Health and Human Services, Education, and Related Agencies (LHHS) bill for Fiscal Year 2026. Lobbied for the reversal of the administration's significant and abrupt terminations of Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for addiction care. Joined coalition letter to the U.S. Department of Health and Human Services (HHS) seeking clarification that an existing, single consent for treatment, payment, and health care operations under 42 CFR Part 2 (Part 2) satisfies the H.R. 1 substance use disorder (SUD) community engagement exemption requirements. ASAM has urged the Centers for Medicare & Medicaid Services (CMS) to update Medicare payment and coding policies for outpatient substance use disorder (SUD) treatment to reflect advances in treatment standards. In a letter to CMS Administrator Oz, highlighted several issues necessitated the need to update existing SUD office-based bundled codes, including changes in The ASAM Criteria, the absence of codes to appropriately describe medically managed outpatient treatment, and data showing that millions of Medicare beneficiaries continue to lack access to treatment. Submitted comment letter to the Centers for Medicare and Medicaid Services (CMS) in response to their request for information related to Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). In comments to the agency, ASAM emphasized the need to balance protecting patients from fraud, waste, and abuse (FWA) with simultaneously protecting patient access to legitimate treatment options. Joined coalition letter to Members of Congress offering revisions to H.R. 5629 to promote safety, integrated care, affordability, patient choice, and provider diversification in the context of methadone treatment for opioid use disorder. Joined coalition letter to Members of Congress regarding appropriations bills for Fiscal Year (FY) 2027, calling on Congress to provide $310 million in funding for tobacco prevention and cessation initiatives run by the Centers for Disease Control and Prevention (CDC). In a letter to the Centers for Medicare and Medicaid Services (CMS), ASAM urged federal officials not to finalize parts of a newly proposed rule that could make it harder for people to get addiction treatment services. ASAM warned that proposed changes for essential health benefits (EHBs) could unintentionally lead states to scale back coverage for SUD treatment. ASAM also raised alarms about proposed changes to allow marketplace insurers to operate with fewer or even no contracted providers, and remove network adequacy standards like time/distance, and appointment wait times. Sent embargoed copy of ASAM's Implementation Guide for Hospital and Emergency Department Substance Use Disorder Care and cannabis use disorder guideline proposals to ONDCP for its review.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68378,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CORREDOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":8,"name":"Congressional Budget Office (CBO)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3cf32bad-367f-48ba-a709-733648c3e69b/","filing_uuid":"3cf32bad-367f-48ba-a709-733648c3e69b","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/3cf32bad-367f-48ba-a709-733648c3e69b/print/","filing_document_content_type":"text/html","income":null,"expenses":"205809.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Mike Troubh","dt_posted":"2026-04-20T11:13:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine AVE SW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":3151,"url":"https://lda.gov/api/v1/registrants/3151/","house_registrant_id":30489,"name":"AMERICAN PSYCHIATRIC ASSOCIATION","description":null,"address_1":"800 Maine AVE SW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABIGAIL GRIFFIN","contact_telephone":"+1 585-590-9005","dt_updated":"2026-07-28T16:38:17.095763-04:00"},"client":{"id":103634,"url":"https://lda.gov/api/v1/clients/103634/","client_id":12,"name":"AMERICAN PSYCHIATRIC ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Fiscal Year 2026 (FY2026) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":142197,"prefix":null,"prefix_display":null,"first_name":"DANA","nickname":null,"middle_name":null,"last_name":"DORAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.1096 - HOPE and Mental Wellbeing Act of 2025 H.R. 929/S. 266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S. 779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1585/S. 709 - Conrad State 30 and Physician Access Reauthorization Act H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S. 931 - COMPLETE Care Act H.R. 4206/S. 1261 - CONNECT for Health Act H.R. 1305 - Improving Measurements for Loneliness and Isolation Act H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act H.R. 2223 - Building Capacity for Care Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 3266/S.1673 - Mental Health Infrastructure Improvement Act of 2025 Mental Health Matters Act H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2587 - Youth Mental Health Research Act H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 2630 - Youth Suicide Prevention Research Act H.R. 3655 - STAR Plus Scholarship Act H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025 H.R. 3885/S.3989 - Community TEAMS Act H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act H.R. 4723/S. 2446 - Mental Health for Latinos Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505 - Barriers to Suicide Act Letters to Congress to extend the enhanced premium tax credits H.R.6249 - Addressing Addiction After Disasters Act H.R.7394/S.3783 - Mental Health Career Promotion Act H.R. 5074 - Protecting Young Minds Online Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R.1197 - PREEMIE Reauthorization Act of 2025 H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act H.Res.792 - Youth Mental Health Day and Suicide Prevention Day Resolution H.R.5725 - Mental Health Crisis Response Act of 2025 H.R.5706 - Mental Health Emergency Responder Act S. 3064 - Relief of Chronic Pain Act H.R. 6226 - Latino Youth Mental Health Empowerment Act H.R. 5482 - Prevent Youth Suicide Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Letter to Letter to Department of Labor, Department of Health and Human Services, and Department of Treasury regarding mental health parity enforcement H.R. 3492 - Protect Children's Innocence Act H.R. 498 - Do No Harm in Medicaid Act H.R. 6817/ S. 1056 - Home-Based Telemental Health Care Act Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks S. 3486 - Expand the Behavioral Health Workforce Now Act H.R.7324/S. 683 - More Behavioral Health Providers Act H.R. 786/S. 1460 - Preserving Patient Access to Accountable Care Act H.R. 4331 - Access to Claims Data Act H.R.5281 - REAL Health Providers Act H.R.7875 - Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act Response to HHS proposed rule on nondiscrimination on the basis of disability Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding H.R. 6396 - Kid PROOF Act H.R. 6468 - Rural Residency Planning and Development Act of 2025 H.R. 8234 - Save Money, Save Lives Act H.R.7092 - RAYS Act H.R.7787 - Mental Health Workforce Act Letter in support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":142197,"prefix":null,"prefix_display":null,"first_name":"DANA","nickname":null,"middle_name":null,"last_name":"DORAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146179,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"MAGUIRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Letter to CMS outlining recommendations for the Medicaid Community Engagement Provisions of H.R.1 Letter to CMS regarding Medicaid and CHIP funding for gender affirming care proposed rule Letter to CMS regarding conditions of participation for gender affirming care proposed rule Response to CMS Medicare Advantage and Medicare Part D 2027 proposed rule Letter to CMS regarding hospital signage guidance Letter to CMS regarding Patient Protection and Affordable Care Act Benefit and Payment Parameters 2027 proposed rule Letter to CMS regarding support for Suicide Safety Planning, and The Collaborative Care Model","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146179,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"MAGUIRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter to Department of Education to preserve federal loan exception that allows medical students and other health professions to borrow additional Unsubsidized Direct loans Letter to Department of Education regarding proposed amendments to federal student loan limits Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142197,"prefix":null,"prefix_display":null,"first_name":"DANA","nickname":null,"middle_name":null,"last_name":"DORAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"APA Letter to the CDC on the extension of the Maternal Mortality Review Information Application","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/53ea8bc0-a767-41bb-b4d4-ef5f1866bb8a/","filing_uuid":"53ea8bc0-a767-41bb-b4d4-ef5f1866bb8a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/53ea8bc0-a767-41bb-b4d4-ef5f1866bb8a/print/","filing_document_content_type":"text/html","income":null,"expenses":"400000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"MaryAnne Sapio","dt_posted":"2026-04-20T14:07:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 Crystal Drive","registrant_address_2":"Suite 540","registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":401040928,"url":"https://lda.gov/api/v1/registrants/401040928/","house_registrant_id":null,"name":"AMERICAN ASSOCIATION OF NURSE PRACTITIONERS","description":"Represent nurse practitioners","address_1":"1400 Crystal Drive","address_2":"Suite 540","address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARYANNE SAPIO","contact_telephone":"+1 703-740-2529","dt_updated":"2026-07-22T10:39:30.715212-04:00"},"client":{"id":197209,"url":"https://lda.gov/api/v1/clients/197209/","client_id":12,"name":"AMERICAN ASSOCIATION OF NURSE PRACTITIONERS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled \"Medications for the Treatment of Opioid Use Disorder\", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act Provider neutral language in federal forms, documents and surveys","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/a8e657fa-5ed0-4032-a521-3c1f39102e74/","filing_uuid":"a8e657fa-5ed0-4032-a521-3c1f39102e74","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/a8e657fa-5ed0-4032-a521-3c1f39102e74/print/","filing_document_content_type":"text/html","income":null,"expenses":"6080000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Stacey Hughes","dt_posted":"2026-04-20T15:58:39-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 10th STREET, NW","registrant_address_2":"Two City Center, Suite 400","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":2571,"url":"https://lda.gov/api/v1/registrants/2571/","house_registrant_id":30635,"name":"AMERICAN HOSPITAL ASSOCIATION","description":null,"address_1":"800 10th Street NW","address_2":"Two City Center, Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CRYSTAL CHILDS","contact_telephone":"","dt_updated":"2026-07-28T14:58:16.299865-04:00"},"client":{"id":103572,"url":"https://lda.gov/api/v1/clients/103572/","client_id":12,"name":"AMERICAN HOSPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 2761 / H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act , all provisions; H.R. 5142, The Home Health Stabilization Act, all provisions; H.R. 4313 / S. 2237, Hospital Inpatient Services Modernization Act of 2025, all provisions; S. 1261 / H.R. 4206, CONNECT for Health Act of 2025, all provisions; H.R. 1805, Assistance for Rural Community Hospitals (ARCH) Act, all provisions; H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions; S. 335, Rural Hospital Support Act, all provisions; S.1816 / H.R.3514 , Improving Seniors Timely Access to Care Act, all provisions; S. 502 / H.R. 6240 , Rural Hospital Closure Relief Act, all provisions; S. 2439 / H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions; H.R. 4002, Patient Access to Higher Quality Health Care Act, all provisions; DRAFT, Blood Pressure MATTERS Act, all provisions; H.R. 5454/S. 2879, the Medicare Advantage Prompt Pay Act, all provisions; DRAFT, Rural Teaching Hospital Relief, all provisions; S. 2793, Ensuring Access to Essential Providers, all provisions; H.R. 10136, Promoting Fairness for Medicare Providers Act, all provisions; H.R. 7409, Defend Rural Health Act, all provisions; H.R. 7830, Women Expansion of Learning and Labor Safety (WELLS) Act, all provisions; Centers for Medicare and Medicaid Services (CMS), Issues pertaining completing the CMS Outpatient Prospective Payment System Drug Acquisition Cost Survey; Centers for Medicare and Medicaid Services (CMS), Issues pertaining to written guidance on acceptable signage and other materials that hospitals can use in their emergency departments to discourage violent behavior; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the proposed rule on the Increasing Organ Transplant Access Model; Centers for Medicare and Medicaid Services (CMS), Comments pertaining to proposed rule on the Global Benchmark for Efficient Drug Pricing model; The Medicare Payment Advisory Commission (MedPAC), Issues related to proposed payment updates and Medicare Advantage program; Centers for Medicare and Medicaid Services (CMS), Medicare Program Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Issue pertaining to proposed rule for policy and technical changes to the Medicare Advantage and Part D programs in contract year 2027; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the upcoming rulemaking implementing requirements related to hospital off-campus provider-based departments; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the Comprehensive Regulations To Uncover Suspicious Healthcare (CRUSH), which includes efforts to combat fraud waste and abuse in federal health care programs; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to the proposed rulemaking on potential options to foster a more resilient supply chain for American-made personal protective equipment and essential medicines; Centers for Medicare and Medicaid Services (CMS), Issue pertaining to expanding the use of Medicare Conditions of Participation (CoP); Centers for Medicare and Medicaid Services (CMS), Issues pertaining to the proposed Notice of Benefit and Payment Parameters for 2027; Centers for Medicare and Medicaid Services (CMS), Issues pertaining to implementation of unique national provider (NPI) for hospital off-campus provider-based departments as outlined in Consolidated Appropriations Act of 2026; Medicaid Program, Issues pertaining to Medicaid program and how states finance programs, reimburse providers, and determine beneficiary eligibility, and implementation of H.R. 1 provisions related to state directed payments and provider taxes; Site Neutral Payments, Issues related to site neutral payment cuts; Rural Hospitals, Issues pertaining to the sustainability of MDHS, CAHs, SCHs, REH's, implementation of Rural Health Transformation Program, rural reclassification policy; Physician Payments, Issues pertaining to alternative payment models, mental health of workforce, physician reimbursement cuts, Medicare Access & CHIP Reauthorization (MACRA) Reforms; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay and cost-based reimbursement for critical access hospitals under Medicare Advantage, Wasteful and Inappropriate Services Reduction (WISeR) model, transparency in plan denial signatures, inappropriate downcoding; Provider Reimbursements, Issues related to provider reimbursement, site neutral payment cuts, Medicare/Medicaid program funding, facility fees, DSH cuts, oversight; Expiring Health Care Provisions, Issues pertaining to Telehealth, Hospital at Home, MDH/LVA, Medicaid DSH Program; Post Acute Care, Issues pertaining to expanding and protecting patients access to services provided by long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, and home health agencies; Rural Community Hospital Demonstration Project, Issues related to ending the Rural Community Hospital Demonstration Project.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143557,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019.","new":true},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":"Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026.","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":253,"name":"Medicare Payment Advisory Commission (MedPAC)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 4581 / S.2372, 340B PATIENTS Act, all provisions; H.R. 3178 / S. 1600, The Save Healthcare Workers Act, all provisions; H.R. 929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; S. 1874, Title VIII Nursing Workforce Reauthorization Act, all provisions; S. 2169, Rural, Hospital Cybersecurity Enhancement Act, all provisions; H.R. 5283 / S. 2759, Healthcare Workforce Resilience Act, all provisions; S. 3315, Health Care Cybersecurity and Resiliency Act of 2025, all provisions; H.R. 5256, 340B Access Act, all provisions; S. 1929, SEPSIS Act, all provisions; S. 2355 / H.R. 5582, Patients Deserve Price Tags Act, all provisions; H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; S. 3435 / H.R. 6607, The Future Advancement of Academic Nursing, all provisions; H.R. 5428, Medical Student Education Authorization Act of 2025, all provisions; H.R. 7920 / S. 4085, Take Back Our Hospitals Act, all provisions; S. 4208, A bill to establish a demonstration program to provide payments on eligible loans for individuals who are eligible for the National Health Service Corps Loan Repayment Program, all provisions; DRAFT, Conrad 30 Enhancement Bill, all provisions; DRAFT, Rural Maternity Bill, all provisions; S.3788, Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act, all provisions; S.3822, Break Up Big Medicine Act, all provisions; H.R.7727, Sustaining Rural Healthcare Act, all provisions; DRAFT, Preserving Patient Access Act, all provisions; H.R. 5629, Medications for the Treatment of Opioid Use Disorder (OUD), all provisions; S. 4141, Rural Hospital Revitalization Act of 2026, all provisions; H.R. 7478, Patient Debt Relief Act, all provisions; Federal Trade Commission, Issue pertaining to the remarks at the forge Mason Law Review 29th Annual Antitrust Symposium; Department of Health & Human Services / Office of the National Coordinator for Health IT, Issues pertaining to Health Data, Technology and Interoperability; Health Resources and Services Administration (HRSA), Comments pertaining to Eli Lilly and Company policy and impact to 340B hospitals; Health Resources and Services Administration (HRSA), Comments pertaining to Novo Nordisk policy and impact to 340B hospitals; Health Resources and Services Administration (HRSA), Comments pertaining to the request for information on a new 340B rebate model program; Department of Health & Human Services / Office of the National Coordinator for Health IT, Issues pertaining to diagnostic imaging interoperability; U.S. Department of Education, Issues pertaining to proposed rule implementing borrowing limits for federal student loans and impact on health care workforce; U.S. Department of Health & Human Services (HHS), Issues pertaining to accelerating the adoption and use of AI as part of clinical care; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program, including 340B Rebate Model Pilot Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP); Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Issues pertaining to workforce development programs, supporting health care workforce and physician shortages, definitions of professional degree programs and borrowing limits, loan repayment programs for providers in rural and underserved areas, Graduate Medical Education program; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay, white-bagging and brown-bagging policies; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, strengthen health care cybersecurity, cybersecurity workforce, and securing drug supply chains, hospital preparedness program, PAHPA reauthorization, outstanding FEMA COVID payments to hospitals; Price Transparency, Issues related to hospital price transparency; Affordability, Issues pertaining to the cost of health care; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce; AI in Healthcare, Issues pertaining to the use of AI in healthcare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143557,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019.","new":true},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":"Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026.","new":true}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 7148, The Consolidated Appropriations Act, 2026, Division B - Title II (Dept. of Health & Human Services), Division J, Health Care Extenders.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143557,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019.","new":true},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":"Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026.","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Tariffs, Issues pertaining to impact of tariffs on hospitals and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143557,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019.","new":true},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":"Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026.","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; H.R. 4393, Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act of 2025, all provisions; Immigration, Issues pertaining to H1-B Visa Program and other immigration changes, impact to health care workforce.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143557,"prefix":null,"prefix_display":null,"first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, United States Senator Deb Fischer, April 2019- January 5th, 2026. Staff Assistant, Legislative Correspondent, Legislative Aide, United States Senator Marco Rubio, November 2012- April 2019.","new":true},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":"Outreach and Policy Advisor, Congressman Peter Welch - U.S. House of Representatives, May 28th, 2019 - December 31st 2022. Policy Advisor, Senator Peter Welch - U.S. Senate, Jan 3rd, 2023 - Jan16th 2026.","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e8f34b42-916b-4814-b007-f561a00bb8b1/","filing_uuid":"e8f34b42-916b-4814-b007-f561a00bb8b1","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e8f34b42-916b-4814-b007-f561a00bb8b1/print/","filing_document_content_type":"text/html","income":"24000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"G. David Mason","dt_posted":"2026-04-24T14:08:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"3rd floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400660986,"url":"https://lda.gov/api/v1/registrants/400660986/","house_registrant_id":41435,"name":"MASON CONSULTING, LLC","description":"Federal policy consultant","address_1":"412 1st Street SE","address_2":"Suite 3","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"G. DAVID MASON","contact_telephone":"+1 202-251-8107","dt_updated":"2026-08-04T10:38:37.288860-04:00"},"client":{"id":193928,"url":"https://lda.gov/api/v1/clients/193928/","client_id":24,"name":"NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS","general_description":"National professional association for pediatric nurse practitioners","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-09-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Legislation and policies relating to: Potential changes in fiscal year 2026 and fiscal year 2027 funding for nurse education, workforce, and research programs as a result of workforce reductions and reorganization of agencies and programs within the Department of Health and Human Services Appropriations of Title VIII funding for nurse education and nurse workforce development programs and for the National Institute of Nursing Research (NINR) in fiscal years 2026 and 2027 Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) Recognition of nursing as a professional degree in Department of Education Reimagining and Improving Student Education Committee (RISE Committee) Negotiated Rulemaking H.R. 5371, Continuing Appropriations and Extensions Act, 2026 H.R. 6938, Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 H.R. 7147, Further Additional Continuing Appropriations Act, 2026 H.R. 7148, Consolidated Appropriations Act, 2026 S. 2587/H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Legislation and policies related to: Accreditation and curriculum of advance practice nursing education programs Policies and requirements related to federal scholarship and loan repayment programs for advanced practice registered nurses Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) Recognition of nursing as a professional degree in Department of Education Reimagining and Improving Student Education Committee (RISE Committee) Negotiated Rulemaking H.R. 3711/S. 1948, Protecting Our Students by Terminating Graduate Rates that Add to Debt (POST GRAD) Act H.R. 6574, Loan Equity for Advanced Professionals (LEAP) Act H.R. 6677, Professional Degree Access Restoration Act H.R. 6718, Professional Student Degree Act H.R. 6739, Clarity in Professional Degree Act H.R. 6862, Protecting Health Care Workforce Pipelines Act S. 3435/H.R. 6607, Future Advancement of Academic Nursing (FAAN) Act S. 3707/H.R. 7279, Nurse Faculty Shortage Reduction Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Legislation and policies related to: Environmental protections affecting the health and safety of children, families, and health care providers Inflation Reduction Act (P.L. 117-169) provisions related to climate change, clean energy, and environmental health Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 4758, Homeowner Energy Freedom Act H.R. 4246, Home Appliance Protection and Affordability Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Legislation and policies relating to: Potential changes in authorizations for nurse education, workforce, and research programs as a result of workforce reductions and reorganization of agencies and programs within the Department of Health and Human Services Policies related to the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, child vaccine recommendations and schedule, the Vaccines For Children Program, and the Vaccine Injury Compensation Fund Cancellation of federal nursing workforce grants Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Use of provider-neutral and inclusive language in federal documents, forms, and surveys Reintroduction of the Primary and Behavioral Health Care Access Act Reauthorization of the Child Nutrition Act Implementation of 42 USC 300gg-5(a) regarding provider non-discrimination by health plans Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Mental health services and violence prevention Tobacco and vaping prevention and cessation Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 1197/S. 1562, PREEMIE Reauthorization Act H.R. 1435/S. 3714, Family-to-Family Reauthorization Act of 2025 H.R. 1627, Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 1735/S. 779, Early Action and Responsiveness Lifts Youth Minds (EARLY Minds) Act H.R. 1834, Breaking the Gridlock Act H.R. 1909/S. 2621, Preventing Maternal Deaths Act H.R. 2223, Building Capacity for Care Act H.R. 3333, Magnifying Opportunities to Recruit and Educate (MORE) Nurses Act H.R. 3492, Protect Childrens Innocence Act H.R. 3701, Family Vaccine Protection Act H.R. 3884/S. 2011, Telemental Health Care Access Act H.R. 4262/S. 4110, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act H.R. 4340/S. 921, Tyler's Law H.R. 4564, Dillons Law H.R. 4709, Newborn Screening Saves Lives Reauthorization Act of 2025 H.R. 5145, Bipartisan Premium Tax Credit Extension Act H.R. 5434/S. 2826, 988 LGBTQ+ Youth Access Act of 2025 H.R. 5469/S. 2858, Stillbirth Health Improvement and Education (SHINE) for Autumn Act H.R. 5629, To provide that the HHS final rule titled Medications for the Treatment of Opioid Use Disorder (except the portion relating to accreditation of opioid treatment programs) shall have no force or effect H.R. 6088/S. 3281, Restoring Food Security for Families & Farmers Act of 2025 H.R. 6252, Food Assurance and Security Act H.R. 6396, Kid Providing Resources for Optimal Outcomes against Fatalities (Kid PROOF) Act of 2025 H.R. 6561, PREVENT HPV Cancers Act of 2025 H.R. 6703, Lower Health Care Premiums for All Americans Act H.R. 6844, Tobacco TRACE Act H.R. 6845/S. 3569, S.T.O.P. Illegal Vaping Act H.R. 6945/S. 4242, Supporting Pregnant and Parenting Women and Families Act H.R. 7092, Raising Awareness for Youth Suicide (RAYS) Prevention Act H.R. 7567, Farm, Food, and National Security Act of 2026 H.R. 7757, Kids Internet and Digital Safety (KIDS) Act H.R. 7973, Momnibus Act H.R. 8089/S. 4186, Perinatal Workforce Act S. 222/H.R. 649, Whole Milk for Healthy Kids Act of 2025 S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 272, Protect Infant Formula from Contamination Act S. 278, Kids Off Social Media Act S. 705, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act (COPPA 2.0) S. 891, Bipartisan Health Care Act S. 1157/H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1885, Stop the Scroll Act S. 1261, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 S. 1482, National Nursing Workforce Center Act of 2025 S. 1599/H.R. 6394, Midwives for Maximizing Optimal Maternity Services (MOMS) Act of 2025 S. 1748/H.R. 6484, Kids Online Safety Act S. 1874/H.R. 3593, Title VIII Nursing Workforce Reauthorization Act of 2025 S. 2169, Rural Hospital Cybersecurity Enhancement Act S. 2857/H.R. 5448, Protecting Free Vaccines Act S. 2954, Health Care Workforce Expansion Act of 2025 S. 3199, 988 Lifeline Location Improvement Act of 2025 S. 3315, Health Care Cybersecurity and Resiliency Act of 2025 S. 3386, Health Care Freedom for Patients Act of 2025 S. 3853, End the Vaccine Carveout Act S. 4088, Welcome Back to the Health Care Workforce Act S. 4189, Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Legislation and policies related to: Detentions and deportation of children and families with children Authorization of the Deferred Action for Childhood Arrivals program Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 1061/S. 455, Protecting Sensitive Locations Act H.R. 6987/S. 3602 - Public Charge Clarification Act of 2025 H.R. 7640, Shut Down Sanctuary Policies Act S. 3805, End Sanctuary Cities Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Legislation and policies related to: Workplace safety and violence prevention for nurse, advanced practice registered nurses, and other health care professionals Implementation of 42 USC 300gg-5(a) regarding provider non-discrimination by health plans H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Services Workers Act H.R. 3170/S. 3296, Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 4122/S. 2167, Health Care for Energy Workers Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":167,"name":"Occupational Safety & Health Administration (OSHA)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Legislation and policies related to: Physician/nurse practitioner reimbursement Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Creation of a Medicare graduate nursing education program Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Medicare and Medicaid policies related to telehealth services Medicaid eligibility expansion and state options Medicaid waiver application procedures Protection and improvement of Medicaid Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21), including the Rural Health Transformation Program Inclusion of nurse practitioners in the bonus program for clinicians practicing in primary care Health Professional Shortage Areas (HPSAs) H.R. 498, Do No Harm in Medicaid Act H.R. 1317/S. 575, Improving Care and Access to Nurses (I CAN) Act H.R. 1616/S. 1805, Promoting Access to Diabetic Shoes Act H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2586, Reentry Act of 2025 H.R. 3108/S. 1535, Rural Patient Monitoring Access Act H.R. 3684, Save Americas Rural Hospitals Act H.R. 4231/S. 1973, Treat and Reduce Obesity Act H.R. 4619, Medicare Mental Health Inpatient Equity Act of 2025 H.R. 4773/S. 3350, ACO Assignment Improvement Act of 2025 H.R. 4849/S. 2556, Protecting Health Care and Lowering Costs Act H.R. 5081/S. 2709, Telehealth Modernization Act H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217, Rural Behavioral Health Improvement Act of 2025 H.R. 6199/S. 3934, Medical Nutrition Therapy Act of 2025 H.R. 7106, Enhancing Skilled Nursing Facilities Act H.R. 7787, Mental Health Workforce Act H.R. 7973, Momnibus Act S. 683/H.R. 7324, More Behavioral Health Providers Act S. 717/H.R. 6894, Increasing Access to Quality Cardiac Rehabilitation Care Act S. 1261/H.R. 4206, CONNECT for Health Act of 2025 S. 1816/H.R. 3514, Improving Seniors Timely Access to Care Act S. 1941, Cure Hepatitis C Act of 2025 S. 2954, Health Care Workforce Expansion Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Legislation and policies related to: Taxation of income and benefits and tax incentives affecting nursing education and practice Taxation of non-profit organizations Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 593, Strengthening Pathways to Health Professions Act H.R. 1582/S. 786, Personal Health Investment Today (PHIT) Act H.R. 3145/S. 1548, Nurse Corps Tax Parity Act of 2025 S. 46/H.R. 247, Health Care Affordability Act of 2025 S. 131/H.R. 392, Providing Real-World Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Legislation and policies related to: Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses H.R. 2234, Ensuring Veterans Timely Access to Anesthesia Care Act S. 3329/H.R. 6203, U.S. Cadet Nurse Corps Service Recognition Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53358,"prefix":"mr","prefix_display":"MR.","first_name":"GLEN","nickname":null,"middle_name":"DAVID","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b16a8130-a66e-44ee-ae12-b27589f29726/","filing_uuid":"b16a8130-a66e-44ee-ae12-b27589f29726","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b16a8130-a66e-44ee-ae12-b27589f29726/print/","filing_document_content_type":"text/html","income":null,"expenses":"69462.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Colette Alston","dt_posted":"2026-07-20T08:40:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 12th Street NW","registrant_address_2":"Suite 700","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":400577734,"url":"https://lda.gov/api/v1/registrants/400577734/","house_registrant_id":null,"name":"ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS","description":"ABHW is the national voice for companies that manage behavioral health & wellness services","address_1":"700 12th Street NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"COLETTE ALSTON","contact_telephone":"+1 202-499-2280","dt_updated":"2026-07-20T08:21:58.745723-04:00"},"client":{"id":192996,"url":"https://lda.gov/api/v1/clients/192996/","client_id":12,"name":"ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-11-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Suicide prevention and crisis services -Behavioral Health Workforce Shortages - Mental Health and Substance Use Disorder Parity - advocating for uniformity and clearer regulations for non-quantitative treatment limitations - Telehealth Expansion Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71094,"prefix":null,"prefix_display":null,"first_name":"MAEGHAN","nickname":null,"middle_name":null,"last_name":"GILMORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141004,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":148243,"prefix":"ms","prefix_display":"MS.","first_name":"DEBORAH","nickname":null,"middle_name":"MILLER","last_name":"WITCHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154409,"prefix":null,"prefix_display":null,"first_name":"LYDIA","nickname":null,"middle_name":null,"last_name":"HOMOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"-Expand access to medication-assisted treatment -Drug Enforcement Agency (DEA) - rules for prescribing controlled medications via telemedicine -Contingency Management -Modernizing Opioid Treatment Access Act (MOTAA) 2.0 (S. 4941) -H.R. 5629 - bill to nullify SAMHSA rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71094,"prefix":null,"prefix_display":null,"first_name":"MAEGHAN","nickname":null,"middle_name":null,"last_name":"GILMORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141004,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":148243,"prefix":"ms","prefix_display":"MS.","first_name":"DEBORAH","nickname":null,"middle_name":"MILLER","last_name":"WITCHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154409,"prefix":null,"prefix_display":null,"first_name":"LYDIA","nickname":null,"middle_name":null,"last_name":"HOMOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Telehealth, reforming barriers to access to services. Extending flexibilities and repealing the 6-month in person visit requirement. -The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act -Medicaid reform -Medicaid community engagement requirements -42 CFR Part 2 as it relates to Medicaid community engagement requirements -Coverage of Peer Support specialists' services","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71094,"prefix":null,"prefix_display":null,"first_name":"MAEGHAN","nickname":null,"middle_name":null,"last_name":"GILMORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141004,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":148243,"prefix":"ms","prefix_display":"MS.","first_name":"DEBORAH","nickname":null,"middle_name":"MILLER","last_name":"WITCHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154409,"prefix":null,"prefix_display":null,"first_name":"LYDIA","nickname":null,"middle_name":null,"last_name":"HOMOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/9167f1d4-5db1-473f-905f-43c00690167b/","filing_uuid":"9167f1d4-5db1-473f-905f-43c00690167b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/9167f1d4-5db1-473f-905f-43c00690167b/print/","filing_document_content_type":"text/html","income":null,"expenses":"137391.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Mike Troubh","dt_posted":"2026-07-20T11:30:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine AVE SW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":3151,"url":"https://lda.gov/api/v1/registrants/3151/","house_registrant_id":30489,"name":"AMERICAN PSYCHIATRIC ASSOCIATION","description":null,"address_1":"800 Maine AVE SW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABIGAIL GRIFFIN","contact_telephone":"+1 585-590-9005","dt_updated":"2026-07-28T16:38:17.095763-04:00"},"client":{"id":103634,"url":"https://lda.gov/api/v1/clients/103634/","client_id":12,"name":"AMERICAN PSYCHIATRIC ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"APA response to NIH-Wide strategic plan framework for fiscal years 2027-2031","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":139,"name":"Natl Institutes of Health (NIH)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Response to OMB proposed rule, Regulation for Federal Financial Assistance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 929/S.266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 879/S.1640 - Medicare Patient Access and Practice Stabilization Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S.475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S.779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1585/S.709 - Conrad State 30 and Physician Access Reauthorization Act H.R. 1909/S.2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S.931 - COMPLETE Care Act H.R. 4206/S.1261 - CONNECT for Health Act H.R. 1305 - Improving Measurements for Loneliness and Isolation Act H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act H.R. 2223 - Building Capacity for Care Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 3266/S.1673 - Mental Health Infrastructure Improvement Act of 2025 H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2587 - Youth Mental Health Research Act H.R. 2483/S.2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 2630 - Youth Suicide Prevention Research Act H.R. 3655 - STAR Plus Scholarship Act H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025 H.R. 3885/S.3989 - Community TEAMS Act H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act H.R. 4723/S. 2446 - Mental Health for Latinos Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505 - Barriers to Suicide Act H.R.6249 - Addressing Addiction After Disasters Act H.R.7394/S.3783 - Mental Health Career Promotion Act H.R. 5074 - Protecting Young Minds Online Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R.1197 - PREEMIE Reauthorization Act of 2025 H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act H.Res.792 - Youth Mental Health Day and Suicide Prevention Day Resolution H.R.5725 - Mental Health Crisis Response Act of 2025 H.R.5706 - Mental Health Emergency Responder Act S. 3064 - Relief of Chronic Pain Act H.R. 6226 - Latino Youth Mental Health Empowerment Act H.R. 5482 - Prevent Youth Suicide Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Letter to Letter to Department of Labor, Department of Health and Human Services, and Department of Treasury regarding mental health parity enforcement H.R. 3492 - Protect Children's Innocence Act H.R. 498 - Do No Harm in Medicaid Act H.R. 6817/ S. 1056 - Home-Based Telemental Health Care Act Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks S. 3486 - Expand the Behavioral Health Workforce Now Act H.R.7324/S. 683 - More Behavioral Health Providers Act H.R. 786/S. 1460 - Preserving Patient Access to Accountable Care Act H.R. 4331 - Access to Claims Data Act H.R.5281 - REAL Health Providers Act H.R.7875 - Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding H.R. 6396 - Kid PROOF Act H.R. 6468 - Rural Residency Planning and Development Act of 2025 H.R. 8234 - Save Money, Save Lives Act H.R.7092 - RAYS Act H.R.7787 - Mental Health Workforce Act Letter in support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act H.R. 8124 - STOP Suicide Act S.1924 / H.R.3624 - Improving Mental Health Access for Students Act H.R.8261 - Chronic Care Management Act Letter in support of funding for the Pediatric Mental Health Care Access program H.R. 8201 - Expanding Community Access to Health Services Act Letter supporting increased funding for Childrens Hospital Graduate Medical Education Letter expressing concerns over H.R. 5629 and H.R. 5630 S. 1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4110 - EMPOWER for Health Act H.R. 9044 - Minority Fellowship Program Reauthorization Act of 2026 H.R. 8163 - Provider Reimbursement Stability Act H.R.8961 - Student Suicide Prevention Awareness Act H.Res.1329 - Expressing support for the designation of May 2026 as Mental Health Awareness Month H.R.8989 - Evidence-Based Youth Suicide Prevention Act of 2026 H.R.8122/ S.4640 - 9-8-8 Connect Act H.R.8811/S.4552 - Moms Matter Act H.R.9257 - Primary and Behavioral Health Care Access Act H.R.8487/S.3401 - Ensuring Excellence in Mental Health Act Joint letter to SAMHSA regarding the planned removal of SAMHSAs buprenorphine practitioner locator and pharmacy locator.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":146179,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"MAGUIRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act H.R.8044 - Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Letter to CMS outlining recommendations for the Medicaid Community Engagement Provisions of H.R.1 Letter to CMS regarding Medicaid and CHIP funding for gender affirming care proposed rule Letter to CMS regarding conditions of participation for gender affirming care proposed rule Response to CMS Medicare Advantage and Medicare Part D 2027 proposed rule Letter to CMS regarding hospital signage guidance Letter to CMS regarding Patient Protection and Affordable Care Act Benefit and Payment Parameters 2027 proposed rule Letter to CMS regarding support for Suicide Safety Planning, and The Collaborative Care Model Letter to CMS in response to RFI on Step Therapy Letter to CMS regarding Interoperability Standards and Prior Authorization proposed rule Letter to CMS regarding Hospital Inpatient Prospective Payment System and Quality Reporting Program 2027 proposed rule Letter to CMS regarding Inpatient Psychiatric Facility Quality Reporting Program and Prospective Payment System 2027 proposed rule Joint letter to HHS, Treasury, and Labor regarding implementation and CMS enforcement of the No Surprises Act Coalition letter to Senator Cassidy, Senator Smith, Representative Tonko, and Representative Huizenga regarding support of Removing Medicare Mental Health Inpatient Limitations Act (S.4076) and the Medicare Mental Health Inpatient Equity Act (H.R. 4619) Joint communication to CMS regarding the implementation of Medicaid eligibility and community engagement requirements under H.R. 1.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146179,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"MAGUIRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2f590e30-7a4c-43f4-8367-63a64a36311a/","filing_uuid":"2f590e30-7a4c-43f4-8367-63a64a36311a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/2f590e30-7a4c-43f4-8367-63a64a36311a/print/","filing_document_content_type":"text/html","income":null,"expenses":"400000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"MaryAnne Sapio","dt_posted":"2026-07-20T12:52:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 Crystal Drive","registrant_address_2":"Suite 540","registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":401040928,"url":"https://lda.gov/api/v1/registrants/401040928/","house_registrant_id":null,"name":"AMERICAN ASSOCIATION OF NURSE PRACTITIONERS","description":"Represent nurse practitioners","address_1":"1400 Crystal Drive","address_2":"Suite 540","address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARYANNE SAPIO","contact_telephone":"+1 703-740-2529","dt_updated":"2026-07-22T10:39:30.715212-04:00"},"client":{"id":197209,"url":"https://lda.gov/api/v1/clients/197209/","client_id":12,"name":"AMERICAN ASSOCIATION OF NURSE PRACTITIONERS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599/H.R. 6394 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482/H.R. 4407 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled \"Medications for the Treatment of Opioid Use Disorder\", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act H.Res. 1264/S.Res. 709 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2026. H.R. 8163 - the Provider Reimbursement Stability Act H.R. 8261 - Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies H.R. 9257/S. 4754 - Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations Act, 2027 H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] implementation and federal student loan limits Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Supporting nursing as a professional degree Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 2332/S. 1101 - States Handling Access to Reciprocity for Employment (SHARE) Act. Provider neutral language in federal forms, documents and surveys","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act H.R. 8163 - the Provider Reimbursement Stability Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act S. 3329/H.R. 6203 - U.S. Cadet Nurse Corps Service Recognition Act of 2025 Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4568/H.R. 8691 - Nursing is a Professional Degree Act H.R. 6718 - Professional Student Degree Act H.J. Res. 189 / S.J. Res. 196 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to \"Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027 H.R. 3170/S. 3296 - Improving Access to Workers Compensation for Injured Federal Workers Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"H.R. 8272 - To classify qualified locum tenens professionals and advanced care practitioners as independent contractors for the purposes of the Fair Labor Standards Act of 1938 and the National Labor Relations Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/c4b725dd-bf6b-41c1-8911-1e48d0ae5acc/","filing_uuid":"c4b725dd-bf6b-41c1-8911-1e48d0ae5acc","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c4b725dd-bf6b-41c1-8911-1e48d0ae5acc/print/","filing_document_content_type":"text/html","income":null,"expenses":"284000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Abyot Wondimu","dt_posted":"2026-07-20T14:14:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 I Street NW","registrant_address_2":"Suite 1200","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106380,"url":"https://lda.gov/api/v1/registrants/401106380/","house_registrant_id":45443,"name":"TOBACCO-FREE KIDS ACTION FUND","description":null,"address_1":"1400 I Street NW","address_2":"Suite 1200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABYOT WONDIMU","contact_telephone":"+1 202-296-5469","dt_updated":"2026-07-22T14:52:33.345045-04:00"},"client":{"id":51237,"url":"https://lda.gov/api/v1/clients/51237/","client_id":51237,"name":"TOBACCO-FREE KIDS ACTION FUND","general_description":"501(c)(4) organization","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-18"},"lobbying_activities":[{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Legislation:   H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  ","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":136150,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":"J","last_name":"HICKEY","suffix":null,"suffix_display":null},"covered_position":"Sen. Dick Durbin Leg. Asst. for Hlth Policy & Soc. Sec. 2007-2009 Senate Dem. Policy Comte. Policy Adv. 2002-2007 Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte. 2001-2002","new":false},{"lobbyist":{"id":136151,"prefix":null,"prefix_display":null,"first_name":"LUKE","nickname":null,"middle_name":"C.","last_name":"GEORGE","suffix":null,"suffix_display":null},"covered_position":"Congressman Martin Frost Legislative Assistant and Systems Manager April 2003 to January 2005 Congressman Lloyd Doggett Legislative Assistant and Systems Manager January 2005 to July 2007","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills Modernizing Opioid Treatment Access Act S. 1165/H. R. 2586, Reentry Act H.R. 5629 Issues:  Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs FY 2027 National Drug Control Policy Medicaid funding and federal guidance related to harm reduction Agencies Visited:  Centers for Disease Control and Prevention US House of Representatives  US Senate Substance Abuse and Mental Health Services Administration","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140798,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"HIGGINS","last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5039710b-daf6-4c3f-9894-670d5d4305d4/","filing_uuid":"5039710b-daf6-4c3f-9894-670d5d4305d4","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5039710b-daf6-4c3f-9894-670d5d4305d4/print/","filing_document_content_type":"text/html","income":null,"expenses":"290000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Abyot Wondimu","dt_posted":"2026-07-20T14:23:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 I Street NW","registrant_address_2":"Suite 1200","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106380,"url":"https://lda.gov/api/v1/registrants/401106380/","house_registrant_id":45443,"name":"TOBACCO-FREE KIDS ACTION FUND","description":null,"address_1":"1400 I Street NW","address_2":"Suite 1200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABYOT WONDIMU","contact_telephone":"+1 202-296-5469","dt_updated":"2026-07-22T14:52:33.345045-04:00"},"client":{"id":51237,"url":"https://lda.gov/api/v1/clients/51237/","client_id":51237,"name":"TOBACCO-FREE KIDS ACTION FUND","general_description":"501(c)(4) organization","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-18"},"lobbying_activities":[{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Legislation:   H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  ","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":136150,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":"J","last_name":"HICKEY","suffix":null,"suffix_display":null},"covered_position":"Sen. Dick Durbin Leg. Asst. for Hlth Policy & Soc. Sec. 2007-2009 Senate Dem. Policy Comte. Policy Adv. 2002-2007 Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte. 2001-2002","new":false},{"lobbyist":{"id":136151,"prefix":null,"prefix_display":null,"first_name":"LUKE","nickname":null,"middle_name":"C.","last_name":"GEORGE","suffix":null,"suffix_display":null},"covered_position":"Congressman Martin Frost Legislative Assistant and Systems Manager April 2003 to January 2005 Congressman Lloyd Doggett Legislative Assistant and Systems Manager January 2005 to July 2007","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills Modernizing Opioid Treatment Access Act S. 1165/H. R. 2586, Reentry Act H.R. 5629 Issues:  Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs FY 2027 National Drug Control Policy Medicaid funding and federal guidance related to harm reduction Agencies Visited:  Centers for Disease Control and Prevention US House of Representatives  US Senate Substance Abuse and Mental Health Services Administration","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140798,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"HIGGINS","last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/59c316d6-b19d-47ac-9e37-2da885c38ad2/","filing_uuid":"59c316d6-b19d-47ac-9e37-2da885c38ad2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/59c316d6-b19d-47ac-9e37-2da885c38ad2/print/","filing_document_content_type":"text/html","income":null,"expenses":"4470000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Stacey Hughes","dt_posted":"2026-07-20T16:48:15-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 10th STREET, NW","registrant_address_2":"Two City Center, Suite 400","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":2571,"url":"https://lda.gov/api/v1/registrants/2571/","house_registrant_id":30635,"name":"AMERICAN HOSPITAL ASSOCIATION","description":null,"address_1":"800 10th Street NW","address_2":"Two City Center, Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CRYSTAL CHILDS","contact_telephone":"","dt_updated":"2026-07-28T14:58:16.299865-04:00"},"client":{"id":103572,"url":"https://lda.gov/api/v1/clients/103572/","client_id":12,"name":"AMERICAN HOSPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 2761 / H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, all provisions; H.R. 5142, The Home Health Stabilization Act, all provisions; S. 1261 / H.R. 4206, CONNECT for Health Act of 2025, all provisions; H.R. 1805, Assistance for Rural Community Hospitals (ARCH) Act, all provisions; H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions; S. 335, Rural Hospital Support Act, all provisions; S.1816 / H.R.3514, Improving Seniors Timely Access to Care Act, all provisions; S. 502, Rural Hospital Closure Relief Act, all provisions; S. 2439 / H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions; H.R. 4002, Patient Access to Higher Quality Health Care Act, all provisions; H.R. 5454/S. 2879, the Medicare Advantage Prompt Pay Act, all provisions; H.R. 6240, Rural Hospital Closure Relief Act of 2025, all provisions; DRAFT, Rural Teaching Hospital Relief, all provisions; S. 2793, Ensuring Access to Essential Providers, all provisions; H.R. 8375/ S. 4384, Medicare Advantage Improvement Act, all provisions; H.R. 8967 / S. 4460, Rural Community Hospital Demonstration Program Reauthorization, all provisions; H.R. 9468, Saving Today's Acute Care Resources (STAR) Act, all provisions; H.R. 8261, Chronic Care Management Improvement Act, all provisions; DRAFT, HCA Mission Act, all provisions; DRAFT, To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage Encounter Data, all provisions; DRAFT, To amend title XVIII of the Social Security Act to limit the compensation that may be paid to agents and brokers by Medicare Advantage (MA) organizations, all provisions; DRAFT, Preserving Patient Access Act, all provisions; H.R. 8891, Rural Maternity Options for Medial Support (Rural MOMS) Act, all provisions; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to Medicare Part C & D Reporting Requirements; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the FY2027 proposed rule for the hospital inpatient prospective payment system; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the proposed Comprehensive Care for Joint Replacement Expanded Model (CJR-X); Centers for Medicare & Medicaid Services (CMS) & Department of Health & Human Services (HHS), Issues pertaining to the interoperability standards and prior authorization for drugs; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the FY2027 proposed rule for the long-term care hospital prospective payment system; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to hospital food and nutrition; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the FY2027 proposed rule for skilled nursing facilities (SNFs); Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the FY2027 proposed rule for inpatient rehabilitation facilities (IRFs); Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the FY2027 proposed rule for inpatient psychiatric facilities (IPFs); Medicaid Program, Issues pertaining to Medicaid program and how states finance programs, reimburse providers, and determine beneficiary eligibility, and implementation and mitigation of H.R. 1 provisions related to state directed payments, provider taxes and community engagement requirements; Site Neutral Payments, Issues related to site neutral payment cuts and facility fees; Rural Hospitals, Issues pertaining to the sustainability of MDHS, CAHs, SCHs, REH's, implementation of Rural Health Transformation Program, rural reclassification policy; Physician Payments, Issues pertaining to alternative payment models, mental health of workforce, physician reimbursement cuts, Medicare Access & CHIP Reauthorization (MACRA) Reforms; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay and cost-based reimbursement for critical access hospitals under Medicare Advantage, Wasteful and Inappropriate Services Reduction (WISeR) model, transparency in plan denial signatures, inappropriate downcoding, reducing administrative burdens; Provider Reimbursements, Issues related to provider reimbursement, site neutral payment cuts, Medicare/Medicaid program funding, facility fees; Post Acute Care, Issues pertaining to expanding patients' access to crucial services provided by long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, hospital at home, and home health agencies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 4581 / S.2372, 340B PATIENTS Act, all provisions; H.R. 3178 / S. 1600, The Save Healthcare Workers Act, all provisions; H.R. 929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; S. 1874, Title VIII Nursing Workforce Reauthorization Act, all provisions; S. 2169, Rural Hospital Cybersecurity Enhancement Act, all provisions; H.R. 5283 / S. 2759, Healthcare Workforce Resilience Act, all provisions; S. 3315, Health Care Cybersecurity and Resiliency Act of 2025, all provisions; H.R. 5256, 340B Access Act, all provisions; S. 2355 / H.R. 5582, Patients Deserve Price Tags Act, all provisions; H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; S. 3435 / H.R. 6607, The Future Advancement of Academic Nursing, all provisions; S. 4637, Physician Workforce Optimization Act, all provisions; S.3788 / H.R. 8269, Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act, all provisions; DRAFT, Issues pertaining to post-market surveillance of devices; S.Res.230, A resolution supporting the goals and ideals of National Hospital Week, to be observed from May 11 through May 17, 2025, all provisions; DRAFT, Issues pertaining to medical debt; S. 4568 / H.R. 8691, Nursing is a Professional Degree Act, all provisions; S.J. Res 196, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to \"Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations\", all provisions; H.R. 6718, Professional Student Degree Act, all provisions; DRAFT, Lower Costs More Transparency Act of 2026, all provisions; DRAFT, To amend title XXVII of the Public Health Service Act to require hospitals to post prices on the walls, all provisions; DRAFT, To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to ensure health insurer accountability through publishing of overhead costs and claim payments, all provisions; DRAFT, To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to require the displaying of claim denial rates, all provisions; DRAFT, To amend title XI of the Social Security Act to require mandatory reporting with respect to certain health-related ownership information, all provisions; S. 1482, National Nursing Workforce Center, all provisions; S. 4027, Healthy Competition for Better Care Act, all provisions; H.R. 5629, To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect; all provisions; H.R. 8726, the Protecting Authority and Restoring Tools Necessary for Enforcement by Regulatory States Act of 2026 PARTNERS Act, all provisions; S.3364, Fast Track Healthcare Apprenticeships Act, all provisions; S.4252, WIPP Economic Assistance Assurance Act of 2026, all provisions; H.R. 4470, Removing Burdens From Organ Donation Act, all provisions; U.S. Department of Health & Human Services / Office of the National Coordinator for Health Information Technology, Issue pertaining to standardized set of data elements intended to support nationwide, interoperable electronic data exchange to help ensure consistent health information exchange throughout a patient's health care journey; Health Resources & Services Administration (HRSA), Issue pertaining a revised version of a 340B rebate model pilot program; Health Resources & Services Administration (HRSA), Issue pertaining to Eli Lilly 340B program decisions; Federal Trade Commission & Department of Justice, Issues pertaining to the effectiveness of the Hart-Scott-Rodino (HSR) premerger notification form and implications for hospital field; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program, including 340B Rebate Model Pilot Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP); Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Issues pertaining to workforce development programs, supporting health care workforce and physician shortages, loan repayment programs for providers in rural and underserved areas, Graduate Medical Education program; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay, white-bagging and brown-bagging policies; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, strengthen health care cybersecurity, cybersecurity workforce, and securing drug supply chains, hospital preparedness program, PAHPA reauthorization; Healthcare Price Transparency, Issues related to health care price transparency; Affordability, Issues and policy solutions pertaining to health care affordability and rising costs of health care; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce; AI in Healthcare, Issues pertaining to the use of AI in healthcare; Professional Degree Program Changes, Issues pertaining to new student loan borrowing limits and professional degree programs changes; Drug Prices, Issues pertaining to lowering drug prices, securing drug supply chain, and transparency; Rural Health Transformation Fund, Issues pertaining to implementation of the Rural Health Transformation program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":64,"name":"Federal Trade Commission (FTC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Funding Priorities for Fiscal Year 2027 Labor, Health & Human Services, Education and Related Agencies Appropriations Request Letter, LHHS, House/Senate, Strengthening the health care workforce, maternal and child health, rural health, disaster preparedness, behavioral health and medical research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"DRAFT, Issues pertaining to reporting requirements for nonprofit hospitals; H.R. 9504, Tax Exempt Hospital Transparency Act, all provisions; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status; Tariffs, Issues pertaining to impact of tariffs on hospitals and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; DRAFT, Issues pertaining H-1B visa program; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140649,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JENKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/03149a8f-dd6a-4252-a40b-6992afea094f/","filing_uuid":"03149a8f-dd6a-4252-a40b-6992afea094f","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/03149a8f-dd6a-4252-a40b-6992afea094f/print/","filing_document_content_type":"text/html","income":null,"expenses":"300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Abyot Wondimu","dt_posted":"2026-07-21T10:31:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 I Street NW","registrant_address_2":"Suite 1200","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106380,"url":"https://lda.gov/api/v1/registrants/401106380/","house_registrant_id":45443,"name":"TOBACCO-FREE KIDS ACTION FUND","description":null,"address_1":"1400 I Street NW","address_2":"Suite 1200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABYOT WONDIMU","contact_telephone":"+1 202-296-5469","dt_updated":"2026-07-22T14:52:33.345045-04:00"},"client":{"id":51237,"url":"https://lda.gov/api/v1/clients/51237/","client_id":51237,"name":"TOBACCO-FREE KIDS ACTION FUND","general_description":"501(c)(4) organization","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-18"},"lobbying_activities":[{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Legislation:   H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  ","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":136150,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":"J","last_name":"HICKEY","suffix":null,"suffix_display":null},"covered_position":"Sen. Dick Durbin Leg. Asst. for Hlth Policy & Soc. Sec. 2007-2009 Senate Dem. Policy Comte. Policy Adv. 2002-2007 Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte. 2001-2002","new":false},{"lobbyist":{"id":136151,"prefix":null,"prefix_display":null,"first_name":"LUKE","nickname":null,"middle_name":"C.","last_name":"GEORGE","suffix":null,"suffix_display":null},"covered_position":"Congressman Martin Frost Legislative Assistant and Systems Manager April 2003 to January 2005 Congressman Lloyd Doggett Legislative Assistant and Systems Manager January 2005 to July 2007","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills Modernizing Opioid Treatment Access Act S. 1165/H. R. 2586, Reentry Act H.R. 5629 Issues:  Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs FY 2027 National Drug Control Policy Medicaid funding and federal guidance related to harm reduction Agencies Visited:  Centers for Disease Control and Prevention US House of Representatives  US Senate Substance Abuse and Mental Health Services Administration","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140798,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"HIGGINS","last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/de974cab-3649-4d2e-a10a-3181f5e93113/","filing_uuid":"de974cab-3649-4d2e-a10a-3181f5e93113","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/de974cab-3649-4d2e-a10a-3181f5e93113/print/","filing_document_content_type":"text/html","income":null,"expenses":"54762.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Colette Alston","dt_posted":"2026-10-19T11:43:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 12th Street NW","registrant_address_2":"Suite 700","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":400577734,"url":"https://lda.gov/api/v1/registrants/400577734/","house_registrant_id":null,"name":"ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS","description":"ABHW is the national voice for companies that manage behavioral health & wellness services","address_1":"700 12th Street NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"COLETTE ALSTON","contact_telephone":"+1 202-499-2280","dt_updated":"2026-07-20T08:21:58.745723-04:00"},"client":{"id":192996,"url":"https://lda.gov/api/v1/clients/192996/","client_id":12,"name":"ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-11-21"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Suicide prevention and crisis services -Behavioral Health Workforce Shortages - Mental Health and Substance Use Disorder Parity - advocating for uniformity and clearer regulations for non-quantitative treatment limitations - Telehealth Expansion Act of 2025 - ABA for Autism","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71094,"prefix":null,"prefix_display":null,"first_name":"MAEGHAN","nickname":null,"middle_name":null,"last_name":"GILMORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141004,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":148243,"prefix":"ms","prefix_display":"MS.","first_name":"DEBORAH","nickname":null,"middle_name":"MILLER","last_name":"WITCHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154409,"prefix":null,"prefix_display":null,"first_name":"LYDIA","nickname":null,"middle_name":null,"last_name":"HOMOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ALC","general_issue_code_display":"Alcohol and Drug Abuse","description":"-Expand access to medication-assisted treatment -Drug Enforcement Agency (DEA) - rules for prescribing controlled medications via telemedicine -Contingency Management -Modernizing Opioid Treatment Access Act (MOTAA) 2.0 (S. 4941) -H.R. 5629 - bill to nullify SAMHSA rule -Teleprescribing for controlled substances -SUD treatment facility fraud","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71094,"prefix":null,"prefix_display":null,"first_name":"MAEGHAN","nickname":null,"middle_name":null,"last_name":"GILMORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141004,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":148243,"prefix":"ms","prefix_display":"MS.","first_name":"DEBORAH","nickname":null,"middle_name":"MILLER","last_name":"WITCHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154409,"prefix":null,"prefix_display":null,"first_name":"LYDIA","nickname":null,"middle_name":null,"last_name":"HOMOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":19,"name":"Office of Natl Drug Control Policy (NDCP)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Telehealth, reforming barriers to access to services. Extending flexibilities and repealing the 6-month in person visit requirement. -The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act -Medicaid reform -Medicaid community engagement requirements -42 CFR Part 2 as it relates to Medicaid community engagement requirements -Coverage of Peer Support specialists' services","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71094,"prefix":null,"prefix_display":null,"first_name":"MAEGHAN","nickname":null,"middle_name":null,"last_name":"GILMORE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":141004,"prefix":null,"prefix_display":null,"first_name":"KATHRYN","nickname":null,"middle_name":null,"last_name":"COHEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":148243,"prefix":"ms","prefix_display":"MS.","first_name":"DEBORAH","nickname":null,"middle_name":"MILLER","last_name":"WITCHEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154409,"prefix":null,"prefix_display":null,"first_name":"LYDIA","nickname":null,"middle_name":null,"last_name":"HOMOVICH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/52559e55-9e65-41c4-a0d5-27a8bc820749/","filing_uuid":"52559e55-9e65-41c4-a0d5-27a8bc820749","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/52559e55-9e65-41c4-a0d5-27a8bc820749/print/","filing_document_content_type":"text/html","income":null,"expenses":"144050.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Mike Troubh","dt_posted":"2026-10-20T09:40:55-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine AVE SW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":3151,"url":"https://lda.gov/api/v1/registrants/3151/","house_registrant_id":30489,"name":"AMERICAN PSYCHIATRIC ASSOCIATION","description":null,"address_1":"800 Maine AVE SW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABIGAIL GRIFFIN","contact_telephone":"+1 585-590-9005","dt_updated":"2026-07-28T16:38:17.095763-04:00"},"client":{"id":103634,"url":"https://lda.gov/api/v1/clients/103634/","client_id":12,"name":"AMERICAN PSYCHIATRIC ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Response to OMB proposed rule, Regulation for Federal Financial Assistance","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142197,"prefix":null,"prefix_display":null,"first_name":"DANA","nickname":null,"middle_name":null,"last_name":"DORAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 929/S.266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S.475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S.779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1909/S.2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S.931 - COMPLETE Care Act H.R. 4206/S.1261 - CONNECT for Health Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2483/S.2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 3655 - STAR Plus Scholarship Act H.R. 3885/S.3989 - Community TEAMS Act H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505/S.5558 - Barriers to Suicide Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act S. 3064 - Relief of Chronic Pain Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Conversations regarding mental health parity enforcement Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks H.R.7092 - RAYS Act Support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act H.R. 8124 - STOP Suicide Act H.R. 8201 - Expanding Community Access to Health Services Act Letter expressing concerns over H.R. 5629 and H.R. 5630 H.R. 9044 - Minority Fellowship Program Reauthorization Act of 2026 H.R. 8163 - Provider Reimbursement Stability Act H.R.8961 - Student Suicide Prevention Awareness Act H.Res.1329 - Expressing support for the designation of May 2026 as Mental Health Awareness Month H.R.8989 - Evidence-Based Youth Suicide Prevention Act of 2026 H.R.8122/ S.4640 - 9-8-8 Connect Act H.R.8811/S.4552 - Moms Matter Act H.R.9257 - Primary and Behavioral Health Care Access Act H.R.8487/S.3401 - Ensuring Excellence in Mental Health Act H.R. 9948 - Addictive Design Act H.R. 9551 - Mental Health Parity Enforcement and Funding Act H.R. 9693 - Patients First Act S.4916 - Aging with Artificial Intelligence Act of 2026 H.R.9538 - Residential Recovery for Seniors Act H.R.10216 - Public Transit Mental Health Awareness Act H.R. 8657 - Campus Lifeline Act H.R. 10349 - Emergency Responders Mental Health Training (EMT) Act H.R. 10210 - Doctors Not AI Act H.R. 8693/S.3062 - GUARD Act H.R.10280 - 9-8-8 Implementation Act of 2026 Letter supporting Project AWARE funding Letter urging prior authorization and step therapy reform National Health Service Corps extension Community Health Center funding extension H.R. 1 implementation impacts on Medicaid Conversation regarding vaccine recommendations and public health Response to HRSA RFI on the Safe Administration of Psychedelic Therapies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":146179,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"MAGUIRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142197,"prefix":null,"prefix_display":null,"first_name":"DANA","nickname":null,"middle_name":null,"last_name":"DORAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act H.R.8044 - Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Letter to HHS regarding Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments Letter to CMS regarding CMS Proposed 2027 Medicare Physician Fee Schedule and Quality Payment Program Rule Coalition letter to CMS regarding Group-Based Interventions in Collaborative Care Coalition letter to CMS regarding the Adoption of Prevention-Focused Cost Measures for Mental Health Care Letter to CMS regarding the Proposed 2027 Hospital Outpatient Prospective Payment System Rule Coalition letter to CMS urging CMS to Withdraw Proposed 50% Payment Reduction for Same-Day E/M Services Letter to HHS regarding Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146179,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"MAGUIRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153555,"prefix":null,"prefix_display":null,"first_name":"REBECCA","nickname":null,"middle_name":null,"last_name":"KILMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155528,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":null,"last_name":"EICHBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act Congressional Review Act (CRA) resolution of disapproval regarding a regulation, entitled Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68253,"prefix":null,"prefix_display":null,"first_name":"MIKAEL","nickname":null,"middle_name":null,"last_name":"TROUBH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147718,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105619,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":"DEXTER","last_name":"STANFORD","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"APA response to the Temporary Scheduling of 7-Hydroxymitragynine (7-OH) APA response to HHSs RFI on the prevention, treatment, and recovery of substance use disorders","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146790,"prefix":null,"prefix_display":null,"first_name":"BROOKE","nickname":null,"middle_name":null,"last_name":"TRAINUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3e406975-22d3-4e20-bce1-88984977adfc/","filing_uuid":"3e406975-22d3-4e20-bce1-88984977adfc","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3e406975-22d3-4e20-bce1-88984977adfc/print/","filing_document_content_type":"text/html","income":null,"expenses":"390000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"MaryAnne Sapio","dt_posted":"2026-10-20T11:14:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 Crystal Drive","registrant_address_2":"Suite 540","registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":401040928,"url":"https://lda.gov/api/v1/registrants/401040928/","house_registrant_id":null,"name":"AMERICAN ASSOCIATION OF NURSE PRACTITIONERS","description":"Represent nurse practitioners","address_1":"1400 Crystal Drive","address_2":"Suite 540","address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARYANNE SAPIO","contact_telephone":"+1 703-740-2529","dt_updated":"2026-07-22T10:39:30.715212-04:00"},"client":{"id":197209,"url":"https://lda.gov/api/v1/clients/197209/","client_id":12,"name":"AMERICAN ASSOCIATION OF NURSE PRACTITIONERS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-03-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599/H.R. 6394 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482/H.R. 4407 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled \"Medications for the Treatment of Opioid Use Disorder\", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973/S. 5283 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act H.Res. 1264/S.Res. 709 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2026. H.R. 8163 - the Provider Reimbursement Stability Act H.R. 8261 - Chronic Care Management Improvement Act S. 5269 - Pay PCPs Act of 2026 H.R. 10410 - Educating Future Nurses Act H.R. 4464 - Preventive Health Savings Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies H.R. 9257/S. 4754 - Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":155,"name":"Drug Enforcement Administration (DEA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations Act, 2027 H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] implementation and federal student loan limits Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Supporting nursing as a professional degree Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 2332/S. 1101 - States Handling Access to Reciprocity for Employment (SHARE) Act. Provider neutral language in federal forms, documents and surveys","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973/S. 5283 - Momnibus Act H.R. 8163 - the Provider Reimbursement Stability Act H.R. 9693/S. 5672 - Patients First Act of 2026 Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act S. 3329/H.R. 6203 - U.S. Cadet Nurse Corps Service Recognition Act of 2025 Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4568/H.R. 8691 - Nursing is a Professional Degree Act H.R. 6718 - Professional Student Degree Act H.J. Res. 189 / S.J. Res. 196 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to \"Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations\" H.R. 6677 - Professional Degree Access Restoration Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027 H.R. 3170/S. 3296 - Improving Access to Workers Compensation for Injured Federal Workers Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"H.R. 8272 - To classify qualified locum tenens professionals and advanced care practitioners as independent contractors for the purposes of the Fair Labor Standards Act of 1938 and the National Labor Relations Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58068,"prefix":null,"prefix_display":null,"first_name":"MARYANNE","nickname":null,"middle_name":null,"last_name":"SAPIO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64744,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"TALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68631,"prefix":null,"prefix_display":null,"first_name":"FRANKLIN","nickname":null,"middle_name":null,"last_name":"HARRINGTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140577,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HORGAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145289,"prefix":"ms","prefix_display":"MS.","first_name":"ANDREA","nickname":null,"middle_name":"MARLENE","last_name":"BERGMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/feaf1aae-b08e-4d0c-963e-f7d9f15eae80/","filing_uuid":"feaf1aae-b08e-4d0c-963e-f7d9f15eae80","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/feaf1aae-b08e-4d0c-963e-f7d9f15eae80/print/","filing_document_content_type":"text/html","income":null,"expenses":"270000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Abyot Wondimu","dt_posted":"2026-10-20T14:15:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1400 I Street NW","registrant_address_2":"Suite 1200","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106380,"url":"https://lda.gov/api/v1/registrants/401106380/","house_registrant_id":45443,"name":"TOBACCO-FREE KIDS ACTION FUND","description":null,"address_1":"1400 I Street NW","address_2":"Suite 1200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ABYOT WONDIMU","contact_telephone":"+1 202-296-5469","dt_updated":"2026-07-22T14:52:33.345045-04:00"},"client":{"id":51237,"url":"https://lda.gov/api/v1/clients/51237/","client_id":51237,"name":"TOBACCO-FREE KIDS ACTION FUND","general_description":"501(c)(4) organization","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-18"},"lobbying_activities":[{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Lobbying Report: July 1st - September 30th , 2026 (Action Fund) Federal (under tobacco issue code)   Legislation:   H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 S. 5526 Agricultural Act of 2026 H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. H.R. 9877/S.5066 Health, Equity, and Accountability Act of 2026 H.R. 10068/S.5312 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA oversight of nicotine pouches FDA regulation of tobacco products[LG1.1] Potential Flavors Legislation Potential [LG2.1]Tobacco Control Legislation Regulation of Menthol Cigarettes Tobacco Impact on Maternal Health Tobacco Graphic Warnings Tobacco User Fees OMB Federal financial Assistance Rule [LG3.1] Tobacco Harm Reduction Modified Risk Tobacco Products Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate Office of Management and Budget Centers for Disease Control and Prevention","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":136150,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":"J","last_name":"HICKEY","suffix":null,"suffix_display":null},"covered_position":"Sen. Dick Durbin Leg. Asst. for Hlth Policy & Soc. Sec. 2007-2009 Senate Dem. Policy Comte. Policy Adv. 2002-2007 Sen. Edward Kennedy (Hlth, Educ. and Pensions Cmte. 2001-2002","new":false},{"lobbyist":{"id":136151,"prefix":null,"prefix_display":null,"first_name":"LUKE","nickname":null,"middle_name":"C.","last_name":"GEORGE","suffix":null,"suffix_display":null},"covered_position":"Congressman Martin Frost Legislative Assistant and Systems Manager April 2003 to January 2005 Congressman Lloyd Doggett Legislative Assistant and Systems Manager January 2005 to July 2007","new":false},{"lobbyist":{"id":155617,"prefix":null,"prefix_display":null,"first_name":"AMANI","nickname":null,"middle_name":null,"last_name":"DESAMOURS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills H.R. 5629- To provide that the final rule of the Department of Health and Human Services titled \"Medications for the Treatment of Opioid Use Disorder\", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 5630- To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants. H.R. 2741 - PEER Support Act S.2948 - WORK to Save Lives Act S. 3522 - No Red Tape Act H.R. 2741/ S. 1329 - Providing Empathetic and Effective Recovery (PEER) Support Act H.R. 2586 - Reentry Act H.R. 1510/ S. 1720 - Due Process Continuity of Care Act S. 5425 - Addiction Grants Modernization Act H.R. 9790/S.4941 - Modernizing Opioid Treatment Access Act 2.0 Issues: Medicaid prior authorization requirements Access to addiction treatment services Overdose prevention Racial disparities in overdose deaths Federal grant funding for addiction treatment services and harm reduction interventions Financing (grants) for behavioral health care services and programs Medicaid and Medicare coverage for addiction treatment services Medicaid funding and federal guidance related to harm reduction Medicaid-supported services during incarceration Congressional naloxone training Women in recovery Substance use disorder workforce expansion CDC Injury Prevention Center programs and funding Methadone access Agencies Visited: US House of Representatives US Senate","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140798,"prefix":"mrs","prefix_display":"MRS.","first_name":"ELIZABETH","nickname":null,"middle_name":"HIGGINS","last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[{"name":"CAMPAIGN FOR TOBACCO-FREE KIDS","url":"www.tobaccofreekids.org","address_1":"1400 I Street NW Suite 1200","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America"}]},{"url":"https://lda.gov/api/v1/filings/5f715aae-6fa2-41fd-b465-39e61cd8a3f2/","filing_uuid":"5f715aae-6fa2-41fd-b465-39e61cd8a3f2","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/5f715aae-6fa2-41fd-b465-39e61cd8a3f2/print/","filing_document_content_type":"text/html","income":null,"expenses":"3840000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Stacey Hughes","dt_posted":"2026-10-20T16:48:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 10th STREET, NW","registrant_address_2":"Two City Center, Suite 400","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":2571,"url":"https://lda.gov/api/v1/registrants/2571/","house_registrant_id":30635,"name":"AMERICAN HOSPITAL ASSOCIATION","description":null,"address_1":"800 10th Street NW","address_2":"Two City Center, Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CRYSTAL CHILDS","contact_telephone":"","dt_updated":"2026-07-28T14:58:16.299865-04:00"},"client":{"id":103572,"url":"https://lda.gov/api/v1/clients/103572/","client_id":12,"name":"AMERICAN HOSPITAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1805, Assistance for Rural Community Hospitals (ARCH) Act, all provisions; S. 1261 / H.R. 4206, CONNECT for Health Act of 2025, all provisions; H.R. 2191, Physician Led and Rural Access to Quality Care Act, all provisions; S. 335, Rural Hospital Support Act, all provisions; S.1816 / H.R.3514, Improving Seniors Timely Access to Care Act, all provisions; S. 502, Rural Hospital Closure Relief Act, all provisions; S. 2439 / H.R. 4731, Resident Physician Shortage Reduction Act of 2025, all provisions; H.R. 4002, Patient Access to Higher Quality Health Care Act, all provisions; H.R. 5454/S. 2879, the Medicare Advantage Prompt Pay Act, all provisions; H.R. 6240, Rural Hospital Closure Relief Act of 2025, all provisions; H.R. 8375/ S. 4384, Medicare Advantage Improvement Act, all provisions; H.R. 8967 / S. 4460, Rural Community Hospital Demonstration Program Reauthorization, all provisions; H.R. 9468, Saving Today's Acute Care Resources (STAR) Act, all provisions; H.R. 8891, Rural Maternity Options for Medial Support (Rural MOMS) Act, all provisions; H.R. 3108 / S. 1535, Rural Patient Monitoring Access Act (RPM Access Act), all provisions; S. 2761 / H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act , all provisions; H.R. 5142, The Home Health Stabilization Act, all provisions; H.R. 8261, Chronic Care Management Improvement Act, all provisions; DRAFT, HCA Mission Act, all provisions; H.R. 9642, Medicare Access to Rural Anesthesiology Act, all provisions; H.R. 9644, Medicare Advantage MLR Transparency Act, all provisions; H.R. 9693, Patients First Act of 2026, all provisions; H.R. 8163, Provider Reimbursement Stability Act of 2026, all provisions; H.R. 8622, Medicare Physician Data-driven Performance Payment system, all provisions; DRAFT, Medicare Provider Reimbursement Step to Stabilization Act of 2026, Issues pertaining to physician fee schedule reforms; H.R.10666, Frontier Community Health Integration Project Extension Act, all provisions; H.R. 1775, Second Chances for Rural Hospitals Act, all provisions; Centers for Medicare & Medicaid Services (CMS), Issues regarding proposed rule on Medicaid managed care state-directed payments and Medicaid fee-for-service targeted practitioner payments; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to funding from the Rural Health Transformation Program and how it is distributed to hospitals; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the physician fee schedule and updates for the CY2027; Centers for Medicare & Medicaid Services (CMS), \"Comments pertaining to the proposed rule regarding the indirect hold harmless threshold of healthcare-related taxes. \"; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to interim final rule on community engagement requirements for certain Medicaid beneficiaries; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2027; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the calendar year 2027 home health prospective payment system proposed rule; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to the CMS proposed rule implementing and codifying the Medicare Drug Benefit Program under the Inflation Reduction Act of 2022; Centers for Medicare & Medicaid Services (CMS), Issues pertaining to Essential Health Benefits framework and Affordable Care Act requirements; Medicaid Program, Issues pertaining to Medicaid program and how states finance programs, reimburse providers, and determine beneficiary eligibility, and implementation and mitigation of H.R. 1 provisions related to state directed payments, provider taxes and community engagement requirements; Site Neutral Payments, Issues related to site neutral payment cuts and facility fees; Rural Hospitals, Issues pertaining to the sustainability of MDHS, CAHs, SCHs, REH's, implementation of Rural Health Transformation Program, rural reclassification policy; Physician Payments, Issues pertaining to alternative payment models, mental health of workforce, physician reimbursement cuts, Medicare Access & CHIP Reauthorization (MACRA) Reforms; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay and cost-based reimbursement for critical access hospitals under Medicare Advantage, Wasteful and Inappropriate Services Reduction (WISeR) model, transparency in plan denial signatures, inappropriate downcoding, reducing administrative burdens; Provider Reimbursements, Issues related to provider reimbursement, site neutral payment cuts, Medicare/Medicaid program funding, facility fees; Post Acute Care, Issues pertaining to expanding patients' access to crucial services provided by long-term care hospitals, inpatient rehabilitation facilities, skilled nursing facilities, hospital at home, and home health agencies; Expiring Health Care Programs, Issues pertaining to expiring health care programs such as GPCI, Physician reimbursement, Medicare Dependent Hospital Program, and Low-Volume Adjustment program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155677,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"SHORT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 4581 / S.2372, 340B PATIENTS Act, all provisions; H.R. 5256, 340B Access Act, all provisions; DRAFT, 340B Drug Pricing Integrity and Affordability for Patients Act, all provisions; H.R. 9599, Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act), all provisions; S. 5244, Supporting Underserved and Strengthening Transparency Accountability and Integrity Now (SUSTAIN) Act, all provisions; H.R. 3178 / S. 1600, The Save Healthcare Workers Act, all provisions; H.R. 929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; S. 1874, Title VIII Nursing Workforce Reauthorization Act, all provisions; S. 2169 / H.R. 9908, Rural Hospital Cybersecurity Enhancement Act, all provisions; H.R. 5283 / S. 2759, Healthcare Workforce Resilience Act, all provisions; S. 3315, Health Care Cybersecurity and Resiliency Act of 2025, all provisions; DRAFT, Health Care Cybersecurity and Resiliency Act of 2026, all provisions; S. 2355 / H.R. 5582, Patients Deserve Price Tags Act, all provisions; H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; S. 3435 / H.R. 6607, The Future Advancement of Academic Nursing, all provisions; DRAFT, Issues pertaining to medical debt; S. 4568 / H.R. 8691, Nursing is a Professional Degree Act, all provisions; S.J. Res 196, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to \"Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations\", all provisions; H.R. 6718, Professional Student Degree Act, all provisions; H.R. 9393, Lower Costs More Transparency Act of 2026, all provisions; S.4252, WIPP Economic Assistance Assurance Act of 2026, all provisions; S.3364, Fast Track Healthcare Apprenticeships Act, all provisions; H.R. 8726, the Protecting Authority and Restoring Tools Necessary for Enforcement by Regulatory States Act of 2026 PARTNERS Act, all provisions; H.R. 5629, To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder, except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect, all provisions; S. 4027, Healthy Competition for Better Care Act, all provisions; S. 1482, National Nursing Workforce Center, all provisions; S. 4637, Physician Workforce Optimization Act, all provisions; H.R. 9390, Prices on the Wall Act of 2026, all provisions; H.R. 9645, Health Care Price Certainty for All Americans Act, all provisions; S. 380 / H.R. 1254, Rural Obstetrics Readiness Act, all provisions; H.R. 9996, No Surprise Bills for New Moms Act, all provisions; H.R. 9862, The Responsible Artificial Intelligence for Veterans Act of 2026, all provisions; S. 5462, Frontier Community Health Integration Project Extension Act (FCHIP Extension Act), all provisions; H.R. 10440, REACH Act, all provisions; DRAFT, Graduate Medical Education (GME), Issues pertaining to graduate medical education (GME) reforms; H.R. 2936 / S. 1974, The Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act, all provisions; H. Res 1519, National Physician Suicide Awareness Day Resolution, Supporting the designation of September 17, 2026, as \"National Physician Suicide Awareness Day\" to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health conditions, and for other purposes; H.R. 5439 / S. 2834, Medically Tailored Home-Delivered Meals Program Pilot Act, all provisions S. 4927, Rural Hospital Emergency Room Guarantee Act, all provisions; Health Resources and Services Administration (HRSA), Issues pertaining to the 340B Rebate Model Pilot Program and information collection request; Consumer Product Safety Commission, Issues pertaining to hospital and health system priorities for the 2027 and 2028 fiscal years; Food & Drug Administration, Issues pertaining to regulation of non-device software such as digital health technology, AI, wellness applications and wearable devices; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program, including 340B Rebate Model Pilot Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP), funding priorities; Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Issues pertaining to workforce development programs, supporting health care workforce and physician shortages, loan repayment programs for providers in rural and underserved areas, Graduate Medical Education program; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay, white-bagging and brown-bagging policies; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, strengthen health care cybersecurity, cybersecurity workforce, and securing drug supply chains, hospital preparedness program, PAHPA reauthorization; Healthcare Price Transparency, Issues related to health care price transparency; Affordability, Issues and policy solutions pertaining to health care affordability and rising costs of health care; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce; AI in Healthcare, Issues pertaining to the use of AI in healthcare and cybersecurity needs; Professional Degree Program Changes, Issues pertaining to new student loan borrowing limits and professional degree programs changes; Drug Prices, Issues pertaining to lowering drug prices, securing drug supply chain, and transparency; Rural Health Transformation Fund, Issues pertaining to implementation of the Rural Health Transformation program; Hospital Mergers & Acquisitions, Issues pertaining to hospital mergers and acquisitions; No Surprises Act, Issues pertaining to No Suprises Act reforms; Health Outcomes, Issues pertaining to prevention, nutrition, and improving health outcomes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155677,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"SHORT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":46,"name":"Consumer Product Safety Commission (CPSC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Office of Management & Budget, Federal Financial Assistance Rule, Issues pertaining to changes to federal grant funding and impact to hospitals and health systems; OMB's Proposed Federal Financial Assistance Rule, Issues pertaining to changes to federal grant funding and impact to hospitals and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155677,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"SHORT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 9504, Tax Exempt Hospital Transparency Act, all provisions; H.R. 10440, REACH Act, all provisions; U.S. Trade Representative, Issues pertaining to proposed duties on certain economies under the Trade Act including medications, medical devices, equipment, PPE and other essential supplies; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status; Tariffs, Issues pertaining to impact of tariffs on hospitals and health systems.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155677,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"SHORT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; DRAFT, Issues pertaining H-1B visa program; U.S. Department of Homeland Security / U.S. Citizenship & Immigration Services, Comments pertaining to the proposed fee for H-1B petitions and impact to health care workforce; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13071,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"CUNDARI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138163,"prefix":"ms","prefix_display":"MS.","first_name":"AIMEE","nickname":null,"middle_name":null,"last_name":"KUHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142980,"prefix":"ms","prefix_display":"MS.","first_name":"PRISCILLA","nickname":null,"middle_name":"ANN","last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62236,"prefix":null,"prefix_display":null,"first_name":"AKINLUWA","nickname":null,"middle_name":"ANDREW","last_name":"DEMEHIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52094,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28230,"prefix":null,"prefix_display":null,"first_name":"ROSLYNE","nickname":null,"middle_name":null,"last_name":"SCHULMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9533,"prefix":null,"prefix_display":null,"first_name":"ASHLEY","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61963,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"WEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61964,"prefix":null,"prefix_display":null,"first_name":"TRAVIS","nickname":null,"middle_name":null,"last_name":"ROBEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":50314,"prefix":"ms","prefix_display":"MS.","first_name":"LISA","nickname":null,"middle_name":null,"last_name":"(KIDDER) HROBSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63958,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67506,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68206,"prefix":null,"prefix_display":null,"first_name":"ARIEL","nickname":null,"middle_name":null,"last_name":"LEVIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71270,"prefix":null,"prefix_display":null,"first_name":"BENJAMIN","nickname":null,"middle_name":"DAVID","last_name":"FINDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98823,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":113723,"prefix":null,"prefix_display":null,"first_name":"SHANNON","nickname":null,"middle_name":null,"last_name":"WU","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":120628,"prefix":null,"prefix_display":null,"first_name":"JASON","nickname":null,"middle_name":null,"last_name":"KLEINMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":78837,"prefix":null,"prefix_display":null,"first_name":"TERRENCE","nickname":null,"middle_name":"P","last_name":"CUNNINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155677,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"SHORT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140650,"prefix":null,"prefix_display":null,"first_name":"DEVIN","nickname":null,"middle_name":null,"last_name":"GERZOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141400,"prefix":null,"prefix_display":null,"first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"GOLD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141401,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"HOLLOMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152298,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTIN","nickname":null,"middle_name":null,"last_name":"HORVATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143558,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"GILLOOLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145189,"prefix":null,"prefix_display":null,"first_name":"BHARATH","nickname":null,"middle_name":null,"last_name":"KRISHNAMURTHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147019,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153668,"prefix":null,"prefix_display":null,"first_name":"EDUARDO","nickname":null,"middle_name":null,"last_name":"SACASA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153669,"prefix":null,"prefix_display":null,"first_name":"THIFEEN","nickname":null,"middle_name":null,"last_name":"DEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}